539607
Blue Cloud Soft. share price & financials
- Price
- ₹20.74
- Market cap
- ₹1.8k Cr
- Sector
- Information Technology
- Calls analysed
- 2
Blue Cloud Soft. Q4 FY26
What went well
- Gross margin expanded significantly to 17% in Q4 FY26, up from 12% in the previous quarter, driven by productization of R&D efforts and premium subscriptions.
- Operating EBITDA margin reached 20% in Q4 FY26, with management expecting this trend to continue.
- The company has a confirmed order book of over ₹1,100 crores for FY27, providing strong revenue visibility.
What to watch
- Account receivables saw an 'unusual spike' and 'slight delay in payments' due to geopolitical situations, though management expects improvement.
- Depreciation for FY27 is expected to be in the same range as Q4 FY26 (₹3 crores quarterly), but the full-year figure is ambiguous, with management stating it won't cross ₹100-120 crores.
What Blue Cloud Soft. does
Blue Cloud Softech Solutions is a Hyderabad-headquartered, AI-first technology company that designs and delivers proprietary AI platforms across surveillance, cybersecurity, healthcare, and telecom infrastructure. Its offerings include the AccessGenie and Blura SAGA surveillance platforms used by law-enforcement agencies, the BluTOR and BluHawk cybersecurity tools, and the patented BluHealth/BioSter healthcare platform that generates vital-parameter readings within seconds using facial recognition. The company also provides IT consulting services, operates through a material subsidiary (IT Corpz Inc), and holds a minority stake in a biosciences venture built on its AI healthcare technology. It earns revenue through a mix of long-term subscription-style contracts and project-based technology deployments for both government and private-sector clients.
Segments
- Cybersecurity
- Safety & Surveillance
- Healthcare
- Telecom Infrastructure
- IT Consulting
- Material subsidiary
- IT Corpz Inc
- Business/technology verticals
- 5 (cybersecurity, safety & surveillance, healthcare, telecom infrastructure, IT consulting)
- Named product platforms
- 6 (AccessGenie, Blura SAGA, BluTOR, BluHawk, BluHealth, BioSter)
- BluHealth vital-parameter scan time
- Under 60 seconds via facial recognition
- Patented technology
- BluHealth platform is patented
- AI development approach
- Proprietary in-house AI algorithms, not dependent on third-party GPT/LLM models
Guidance record · Q4 FY26
what the last two calls moved 14 tracked 0 delivered 0 missed 14 open- Revenue Visibility on track said Q3 FY26 Promised: ₹3,000 crores approximately for FY 2027 Q4 FY26: Reiterated FY27 revenue guidance of ₹3,000 crores. Confirmed order book for FY27 stands at ₹1,100 crores, indicating a reliance on pipeline conversion to meet the full target.
All 14 tracked — every revision, and every one management stopped mentioning.
Open the guidance ledgerQuarterly results
Q1 FY27: revenue up 42.2%, net profit up 28.6% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 235 | 147 | 184 | 206 | 253 +8% | 265 +80% | 278 +51% | 293 +42% |
| EBITDA | 18 | 15 | 17 | 21 | 24 +33% | 33 +120% | 48 +182% | 60 +186% |
| Net profit | 11 | 9 | 13 | 14 | 15 +36% | 19 +111% | 12 −8% | 18 +29% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −37.1% 1Y
1Y: ₹30.54 on 10 Sept 2025 → ₹19.2. High ₹32.95 (4 Nov 2025), low ₹17.03 (27 Jan 2026).
How the price took the results
close before → close after
- Q4 FY26
- +0.5%
- 5 Jun
- Q3 FY26
- −0.0%
- 4 Mar
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Financials, as filed
Revenue grew 25.7% a year over 1 year, FY25 to FY26. Operating margin widened to 12.6%.
| Year ending | FY25 | FY26 |
|---|---|---|
| Revenue | ₹797 Cr | ₹1.0k Cr |
| Operating profit | ₹69 Cr | ₹126 Cr |
| Operating margin | 8.7% | 12.6% |
| Interest | ₹7 Cr | ₹10 Cr |
| Depreciation | ₹3 Cr | ₹26 Cr |
| Net profit | ₹43 Cr | ₹60 Cr |
| Net margin | 5.4% | 6.0% |
| Cash from operations | ₹-13 Cr | ₹208 Cr |
| Free cash flow | ₹-23 Cr | ₹-730 Cr |
| ROCE | 37.0% | 14.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Equity capital | ₹44 Cr | ₹44 Cr | ₹75 Cr |
| Reserves | ₹34 Cr | ₹114 Cr | ₹848 Cr |
| Borrowings | ₹68 Cr | ₹87 Cr | ₹269 Cr |
| Other liabilities | ₹48 Cr | ₹96 Cr | ₹175 Cr |
| Total liabilities | ₹193 Cr | ₹341 Cr | ₹1.4k Cr |
| Fixed assets | ₹52 Cr | ₹56 Cr | ₹970 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹141 Cr | ₹284 Cr | ₹398 Cr |
| Total assets | ₹193 Cr | ₹341 Cr | ₹1.4k Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, FIIs trimmed −9.66 pp while the public added +5.81 pp. The shareholder count grew 116% to 70,124.
- Promoters
- 38.4%
- FIIs
- 13.3%
- Public
- 48.3%
Since Jun 2025
- FIIs −9.66 pp
- Public +5.81 pp
- Promoters +3.86 pp
How it drifted, 12 quarters
Over this window FIIs fell from 22.9% to 13.3% — −9.7 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 38.1%, FIIs 22.9%, Public 39.0%.Dec '23: Promoters 38.0%, FIIs 22.9%, Public 39.0%.Mar '24: Promoters 38.0%, FIIs 22.9%, Public 39.0%.Jun '24: Promoters 36.0%, FIIs 22.9%, Public 41.1%.Sep '24: Promoters 35.8%, FIIs 22.9%, Public 41.3%.Dec '24: Promoters 35.8%, FIIs 23.0%, Public 41.3%.Mar '25: Promoters 35.5%, FIIs 22.9%, Public 41.6%.Jun '25: Promoters 34.6%, FIIs 22.9%, Public 42.5%.Sep '25: Promoters 34.5%, FIIs 22.9%, Public 42.5%.Dec '25: Promoters 38.5%, FIIs 13.3%, Public 48.2%.Mar '26: Promoters 38.4%, FIIs 13.3%, Public 48.3%.Jun '26: Promoters 38.4%, FIIs 13.3%, Public 48.3%.
Who is on the register
Named in the Jun 2026 filing
Every holder of Blue Cloud Soft. above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Yarlagadda Janaki | 38.06% | unchanged |
| Siraj Holding Llc | 23.33% | unchanged |
| Yas Takaful P J S C Insurer | 13.28% | unchanged |
| Blue Sky Capital Fund Spc | 7.00% | −1.28 pp |
| Ittb Software Private Limited | 0.19% | unchanged |
| Janardhana Sharma Doranala | 0.19% | unchanged |
| Venkatarama Raoboinepally | 0.00% | unchanged |
| Chinna Malipeddi | 0.00% | unchanged |
| Durantainfrastructureprivate Limited | 0.00% | unchanged |
| Ravi Kumar Bogha | 0.00% | unchanged |
| Newton Energy Private Limited | 0.00% | unchanged |
| V Sambasiva Rao | 0.00% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
What the price assumes
AttractiveTo justify its price of ₹19, this stock must grow earnings at 14% every year for 7 years. Our analysis caps realistic growth at ~40%. At that growth it is worth ₹68 — upside of 252%.
- Growth the price implies
- 14.2% a year
- for 7 years, fading to 4%
- It has actually compounded at
- 39.5% a year
- net profit, FY25–FY26
- The gap
- -0.3 pp
- 252% downside if it only repeats history
All earnings calls (2)
Read the Q4 FY26 call →Learn to analyse Blue Cloud Soft.
Guides on how to read this kind of business and the numbers that matter.